Midwest Professional Planners Ltd (MPPL)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Sell |
3,425
-30
| -0.9% | -$13.4K | 0.4% | 73 |
|
|
2025
Q1 | $1.68M | Sell |
3,455
-390
| -10% | -$189K | 0.52% | 62 |
|
|
2024
Q4 | $1.55M | Buy |
3,845
+255
| +7% | +$103K | 0.46% | 68 |
|
|
2024
Q3 | $1.67M | Buy |
3,590
+319
| +10% | +$148K | 0.51% | 62 |
|
|
2024
Q2 | $1.53M | Buy |
3,271
+212
| +7% | +$99.4K | 0.51% | 55 |
|
|
2024
Q1 | $1.28M | Buy |
3,059
+357
| +13% | +$149K | 0.45% | 68 |
|
|
2023
Q4 | $1.1M | Buy |
2,702
+172
| +7% | +$70K | 0.44% | 64 |
|
|
2023
Q3 | $880K | Buy |
2,530
+426
| +20% | +$148K | 0.4% | 64 |
|
|
2023
Q2 | $740K | Buy |
2,104
+446
| +27% | +$157K | 0.32% | 78 |
|
|
2023
Q1 | $522K | Buy |
1,658
+192
| +13% | +$60.5K | 0.26% | 84 |
|
|
2022
Q4 | $423K | Buy |
1,466
+264
| +22% | +$76.2K | 0.23% | 87 |
|
|
2022
Q3 | $348K | Buy |
1,202
+104
| +9% | +$30.1K | 0.21% | 91 |
|
|
2022
Q2 | $309K | Buy |
1,098
+146
| +15% | +$41.1K | 0.17% | 94 |
|
|
2022
Q1 | $248K | Buy |
+952
| New | +$248K | 0.12% | 108 |
|